Having trouble viewing this email? See the online version

Monday, September 30, 2024
Monday, September 30, 2024
Johnson and Johnson_Bloomberg 0924
Insurance

J&J drops 340B rebate model following HRSA pressure

The agency said Johnson & Johnson faced sanctions because the plan violated 340B drug discount program rules and had not received federal approval.

Read More >
RELATED ARTICLES
HRSA orders J&J to drop controversial 340B rebate model
Hospitals seek fines against Johnson & Johnson in 340B battle
States build momentum to protect 340B drug discounts - for now

UNLOCK YOUR DISCOUNT

Subscribe and save today to discover the latest news, insight & analysis needed to navigate the healthcare industry.

SUBSCRIBE AND SAVE 50%

 

This email was sent to chunduri22.covid@blogger.com
Manage My Account | Contact Us

 

© 2024 Modern Healthcare
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe